About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

18 Ohio St. J. Crim. L. 99 (2020-2021)
Reconsidering Federal Marijuana Regulation

handle is hein.journals/osjcl18 and id is 107 raw text is: Reconsidering Federal Marijuana Regulation

Paul J. Larkin, Jr.*
ABSTRACT
The Controlled Substances Act (CSA) prohibits the cultivation and
distribution of marijuana by placing it in a category (Schedule I) reserved
for drugs that are unhelpful and dangerous. The CSA has remained
unchanged since its birth, but numerous states have changed their penal
code and now allow the sale of marijuana for medical or recreational
purposes. The current legal status of cannabis is therefore nonsensical
because, try as they might, the states cannot grant private parties a license
to violate federal law. Congress needs to address that problem. In so
doing, Congress should recognize that the CSA approached this problem
from the wrong direction. People use drugs for medical or recreational
purposes, and each one requires a separate regulatory scheme.
Medical Marijuana Use: For more than eighty years, the nation has
entrusted the Commissioner of Food and Drugs with the responsibility to
decide whether a particular substance is a drug and, if so, whether that
drug is safe and effective and therefore can be sold throughout the
nation. Those decisions are neither moral nor political ones. They require
the scientific expertise of professionals in the fields of medicine,
biochemistry, pharmacology, and the like, not the legal knowledge of
lawyers or the ethical sensibilities of the electorate. Congress should leave
to the judgment of the Commissioner the decision of how federal law
should regulate medical-use marijuana.
Recreational Marijuana Use: The disparities between federal and state law
demand reconciliation. Congress and the president should assume that
responsibility and, in so doing, should consider a number of relevant
factors: What effect would legalization have on marijuana use by adults
and juveniles? What percentage of people who engage in long-term use
John, Barbara & Victoria Rumpel Senior Legal Research Fellow, The Heritage Foundation.
The views expressed are my own and should not be construed as representing any official position of
The Heritage Foundation. I want to thank MariBeth Andresen, Douglas Berman, Lucas Drill, Dr. Rob-
ert L. DuPont, Heidi King, John G. Malcolm, Corinne Shea, Katherine C. Skilling, Charles G. Stimson,
William Vodra, Charmaine Yoest, and Patricia J. Zettler for helpful comments on an earlier draft of
this Article. Cooper Conway, Alexis Huggins, and Marcos Mullin provided valuable research assis-
tance. Most importantly, I want to thank the late Professor Mark A.R. Kleiman. Mark died before I put
pen to paper, but he influenced every word in this article. Wherever he is, I hope that the people there
pay as much attention to what he says about drug policy as I have. They will be far better for it.

99

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most